$AORT
ARTIVION, INC.

2021 Q4 Form 10-Q Financial Statement

#000078419921000207 Filed on November 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $79.39M $72.21M $65.13M
YoY Change 16.93% 10.86% -4.05%
Cost Of Revenue $28.02M $24.42M $22.00M
YoY Change 20.23% 11.0% -2.91%
Gross Profit $51.37M $47.79M $43.13M
YoY Change 15.21% 10.8% -4.62%
Gross Profit Margin 64.71% 66.18% 66.22%
Selling, General & Admin $32.14M $39.05M $33.74M
YoY Change 19.17% 15.74% -1.51%
% of Gross Profit 62.56% 81.72% 78.23%
Research & Development $9.460M $9.972M $5.755M
YoY Change 73.28% -8.05%
% of Gross Profit 18.41% 20.87% 13.34%
Depreciation & Amortization $5.969M $6.009M $14.82M
YoY Change 1.27% -59.45%
% of Gross Profit 11.62% 12.57% 34.36%
Operating Expenses $45.81M $49.03M $39.50M
YoY Change 20.95% 24.12% -2.52%
Operating Profit $5.561M $14.69M $3.634M
YoY Change -17.17% 304.16% -22.75%
Interest Expense -$3.873M -$4.082M $4.900M
YoY Change -17.28% -183.31% 36.11%
% of Operating Profit -69.65% -27.79% 134.84%
Other Income/Expense, Net -$2.875M -$2.661M -$2.888M
YoY Change -207.44% -7.86% 20.33%
Pretax Income -$16.09M $7.944M -$4.181M
YoY Change 17385.87% -290.0% 321.47%
Income Tax $4.013M -$2.638M -$1.311M
% Of Pretax Income -33.21%
Net Earnings -$20.10M $10.58M -$2.870M
YoY Change 481.26% -468.71% 2041.79%
Net Earnings / Revenue -25.32% 14.66% -4.41%
Basic Earnings Per Share $0.27 -$0.08
Diluted Earnings Per Share -$513.3K $0.26 -$0.08
COMMON SHARES
Basic Shares Outstanding 39.33M 39.09M 37.91M
Diluted Shares Outstanding 44.45M 37.91M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.01M $64.59M $64.12M
YoY Change -10.42% 0.73%
Cash & Equivalents $55.01M $64.59M $64.12M
Short-Term Investments
Other Short-Term Assets $57.61M $59.26M $50.74M
YoY Change 12.11% 16.78%
Inventory $76.97M $78.32M $69.40M
Prepaid Expenses
Receivables $53.02M $49.68M $46.91M
Other Receivables $5.086M $5.494M $2.520M
Total Short-Term Assets $247.7M $257.3M $233.7M
YoY Change 5.59% 10.12% 28.86%
LONG-TERM ASSETS
Property, Plant & Equipment $37.52M $36.97M $31.80M
YoY Change 13.44% 16.27% 4.49%
Goodwill $250.0M $252.4M $254.0M
YoY Change -3.87% -0.61% 38.52%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.267M $13.22M $14.29M
YoY Change -43.39% -7.47% 1.59%
Total Long-Term Assets $545.4M $561.3M $548.5M
YoY Change -1.71% 2.34% 33.37%
TOTAL ASSETS
Total Short-Term Assets $247.7M $257.3M $233.7M
Total Long-Term Assets $545.4M $561.3M $548.5M
Total Assets $793.1M $818.7M $782.2M
YoY Change 0.46% 4.66% 31.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.40M $9.528M $10.40M
YoY Change 8.02% -8.38% 39.49%
Accrued Expenses $7.687M $9.091M $10.34M
YoY Change 2.88% -12.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.630M $1.640M $1.165M
YoY Change 36.4% 40.77% 1.84%
Total Short-Term Liabilities $44.95M $61.13M $53.67M
YoY Change -25.66% 13.91% 27.2%
LONG-TERM LIABILITIES
Long-Term Debt $307.5M $307.8M $289.7M
YoY Change 5.86% 6.24% 34.87%
Other Long-Term Liabilities $6.484M $12.24M $12.84M
YoY Change -3.08% -4.66% -16.46%
Total Long-Term Liabilities $314.0M $320.0M $302.5M
YoY Change 5.66% 5.77% 31.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.95M $61.13M $53.67M
Total Long-Term Liabilities $314.0M $320.0M $302.5M
Total Liabilities $492.3M $507.1M $456.4M
YoY Change 6.87% 11.1% 44.85%
SHAREHOLDERS EQUITY
Retained Earnings $1.975M $22.08M $23.48M
YoY Change -90.14% -5.98% -37.19%
Common Stock $323.3M $309.7M $316.8M
YoY Change 2.11% -2.24% 17.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $300.7M $311.5M $325.8M
YoY Change
Total Liabilities & Shareholders Equity $793.1M $818.7M $782.2M
YoY Change 0.46% 4.66% 31.99%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$20.10M $10.58M -$2.870M
YoY Change 481.26% -468.71% 2041.79%
Depreciation, Depletion And Amortization $5.969M $6.009M $14.82M
YoY Change 1.27% -59.45%
Cash From Operating Activities $716.0K -$2.909M $6.919M
YoY Change -86.86% -142.04%
INVESTING ACTIVITIES
Capital Expenditures -$2.567M -$3.275M -$5.171M
YoY Change 19.01% -36.67%
Acquisitions
YoY Change
Other Investing Activities -$245.0K $18.79M -$65.61M
YoY Change 29.63% -128.64%
Cash From Investing Activities -$2.812M $15.52M -$70.78M
YoY Change 19.86% -121.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.801M 315.0K 95.29M
YoY Change 423.25% -99.67%
NET CHANGE
Cash From Operating Activities 716.0K -2.909M 6.919M
Cash From Investing Activities -2.812M 15.52M -70.78M
Cash From Financing Activities -8.801M 315.0K 95.29M
Net Change In Cash -10.90M 12.92M 31.43M
YoY Change -866.32% -58.88%
FREE CASH FLOW
Cash From Operating Activities $716.0K -$2.909M $6.919M
Capital Expenditures -$2.567M -$3.275M -$5.171M
Free Cash Flow $3.283M $366.0K $12.09M
YoY Change -56.84% -96.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Entity Central Index Key
EntityCentralIndexKey
0000784199
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13165
dei Entity Registrant Name
EntityRegistrantName
CRYOLIFE INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-2417093
dei Entity Address Address Line1
EntityAddressAddressLine1
1655 Roberts Boulevard, NW
dei Entity Address City Or Town
EntityAddressCityOrTown
Kennesaw
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30144
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
419-3355
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
CRY
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39329580
CY2021Q3 us-gaap Revenues
Revenues
72207000
CY2020Q3 us-gaap Revenues
Revenues
65131000
us-gaap Revenues
Revenues
219442000
us-gaap Revenues
Revenues
185331000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24418000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21999000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
73302000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62138000
CY2021Q3 us-gaap Gross Profit
GrossProfit
47789000
CY2020Q3 us-gaap Gross Profit
GrossProfit
43132000
us-gaap Gross Profit
GrossProfit
146140000
us-gaap Gross Profit
GrossProfit
123193000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39053000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33743000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
118521000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105033000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9972000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5755000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26086000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17633000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
49025000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
39498000
us-gaap Operating Expenses
OperatingExpenses
144607000
us-gaap Operating Expenses
OperatingExpenses
122666000
CY2021Q3 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
15923000
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
15923000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
14687000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3634000
us-gaap Operating Income Loss
OperatingIncomeLoss
17456000
us-gaap Operating Income Loss
OperatingIncomeLoss
527000
CY2021Q3 cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
4100000
CY2020Q3 cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
4940000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
10550000
CY2021Q3 cry Restricted Cash Fair Value Disclosure
RestrictedCashFairValueDisclosure
10550000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12030000
cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
12995000
cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
11980000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
18000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
13000
us-gaap Investment Income Interest
InvestmentIncomeInterest
60000
us-gaap Investment Income Interest
InvestmentIncomeInterest
181000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2661000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2888000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3261000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5810000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7944000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4181000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1260000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17082000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2638000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1311000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4006000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3858000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
us-gaap Net Income Loss
NetIncomeLoss
5266000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39086000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37912000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38924000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37608000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44453000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37912000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39496000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37608000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
us-gaap Net Income Loss
NetIncomeLoss
5266000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5010000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8698000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12327000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8669000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
186091000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5572000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5828000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7061000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4555000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64587000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61412000
CY2021Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
538000
CY2020Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
546000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49682000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45964000
CY2021Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
5494000
CY2020Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2788000
CY2021Q3 us-gaap Inventory Net
InventoryNet
78319000
CY2020Q4 us-gaap Inventory Net
InventoryNet
73038000
CY2021Q3 cry Deferred Preservation Costs
DeferredPreservationCosts
42619000
CY2020Q4 cry Deferred Preservation Costs
DeferredPreservationCosts
36546000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16104000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14295000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
257343000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
234589000
CY2021Q3 us-gaap Goodwill
Goodwill
252441000
CY2020Q4 us-gaap Goodwill
Goodwill
260061000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
171788000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46913000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18571000
CY2021Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
36001000
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
40966000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36973000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33077000
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3974000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1446000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13221000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14603000
CY2021Q3 us-gaap Assets
Assets
818654000
CY2020Q4 us-gaap Assets
Assets
789404000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
17600000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
16430000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9528000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9623000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11990000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10192000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9091000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7472000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
47300000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
43500000
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
27339000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
34713000
CY2021Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5571000
CY2021Q3 cry Accrued Procurement Fees
AccruedProcurementFees
3296000
CY2020Q4 cry Accrued Procurement Fees
AccruedProcurementFees
3619000
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
3129000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2808000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3053000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5763000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1640000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1195000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1803000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3366000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
61130000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60468000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
307765000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
290468000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45765000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14034000
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5518000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12243000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11990000
CY2021Q3 us-gaap Liabilities
Liabilities
507113000
CY2020Q4 us-gaap Liabilities
Liabilities
460691000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40816000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40394000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
408000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
404000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
309290000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
316192000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22075000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20022000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5584000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6743000
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1487000
CY2021Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1487000
CY2021Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
14648000
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
14648000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
311541000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
328713000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
818654000
cry Noncash Lease Expense
NoncashLeaseExpense
5324000
cry Increase Decrease In Fair Value Of Contingent Consideration
IncreaseDecreaseInFairValueOfContingentConsideration
4970000
cry Noncash Interest Expense
NoncashInterestExpense
2025000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
789404000
us-gaap Net Income Loss
NetIncomeLoss
5266000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18008000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14818000
us-gaap Share Based Compensation
ShareBasedCompensation
7471000
us-gaap Share Based Compensation
ShareBasedCompensation
7432000
cry Noncash Lease Expense
NoncashLeaseExpense
5566000
cry Noncash Interest Expense
NoncashInterestExpense
2261000
cry Change In Fair Value Of Long Term Loan
ChangeInFairValueOfLongTermLoan
4949000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
8128000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
4916000
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
15923000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4665000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1631000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
65000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3230000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2268000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2560000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
8032000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7718000
cry Increase Decrease In Deferred Preservation Costs And Inventories
IncreaseDecreaseInDeferredPreservationCostsAndInventories
16986000
cry Increase Decrease In Deferred Preservation Costs And Inventories
IncreaseDecreaseInDeferredPreservationCostsAndInventories
19744000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3301000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6919000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
19000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
59643000
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
5000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10524000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5171000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
968000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8472000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70782000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3531000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2079000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
30000000
cry Proceeds From Financing Insurance Premiums
ProceedsFromFinancingInsurancePremiums
2816000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
30000000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1898000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1768000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2219000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3647000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2397000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3727000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-439000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-463000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3422000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
95290000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1418000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1086000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3167000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30341000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61958000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34294000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65125000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64635000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
301835000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10582000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5010000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2991000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
191000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1019000
CY2021Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
67000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
311541000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
328713000
us-gaap Net Income Loss
NetIncomeLoss
5266000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12327000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7895000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1922000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1609000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1898000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
311541000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
296556000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8698000
CY2020Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
20000000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2518000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
873000
CY2020Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
40000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
325766000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
285696000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2020Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8669000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
20000000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7888000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
518000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1561000
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
16426000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1768000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
325766000
us-gaap Basis Of Accounting
BasisOfAccounting
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span id="Notes" style="text-decoration: none;"/><h3 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">1. Basis of Presentation and Summary of Significant Accounting Policies</span></h3><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Overview</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The accompanying Condensed Consolidated Financial Statements include the accounts of CryoLife, Inc. and its subsidiaries (“CryoLife,” the “Company,” “we,” or “us”). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Condensed Consolidated Balance Sheet as of December 31, 2020 has been derived from audited financial statements. The accompanying unaudited Condensed Consolidated Financial Statements as of, and for the three and nine months ended, September 30, 2021 and 2020 have been prepared in accordance with (i) accounting principles generally accepted in the U.S. for interim financial information and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, such statements do not include all the information and disclosures that are required by accounting principles generally accepted in the U.S. for a complete presentation of financial statements. In the opinion of management, all adjustments (including those of a normal, recurring nature) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. These Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included in CryoLife’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 22, 2021.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Significant Accounting Policies</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">A summary of our significant accounting policies is included in Note 1 of the “Notes to Consolidated Financial Statements” contained in our Form 10-K for the year ended December 31, 2020. Management believes that the consistent application of these policies enables us to provide users of the financial statements with useful and reliable information about our operating results and financial condition. The Condensed Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the U.S., which require us to make estimates and assumptions. We did not experience any significant changes during the three and nine months ended September 30, 2021 in any of our Significant Accounting Policies from those contained in our Form 10-K for the year ended December 31, 2020.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">New Accounting Standards</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Recently Adopted</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In August 2020 the Financial Accounting Standards Board (the “FASB”) issued Accounting Standard Update (“ASU”) Update No. 2020-06, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (“ASU 2020-06”). The update simplifies the accounting for convertible instruments by eliminating two accounting models (i.e., the cash conversion model and beneficial conversion feature model) and reducing the number of embedded conversion features that could be recognized separately from the host contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. On January 1, 2021 we adopted ASU 2020-06 using the modified retrospective approach and recorded $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">20.4</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million to increase long-term debt, $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3.2</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million to reduce retained earnings, and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">16.4</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million to reduce additional paid-in capital included on the Condensed Consolidated Balance Sheets. See Note 11 for further discussion of convertible debt. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In December 2019 the FASB issued </span><span id="keyword" style="text-decoration: none;"/><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ASU No. 2019-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">12, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (“ASU 2019-12”). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">accounting principles generally accepted in the United States of America</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (“GAAP”) for other areas of Topic 740 by clarifying and amending existing guidance. The amendments are effective for public entities in fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. We adopted ASU 2019-12 on January 1, 2021 and the adoption did not have a material impact on our financial condition or results of operations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Not Yet Effective</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In March 2020 the FASB issued ASU 2020-04, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Reference Rate Reform Topic 848</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (“ASC 848”). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. GAAP requires entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December 31, 2022 and cannot be applied to contract modifications that occur after December 31, 2022. </span><span style="white-space:pre-wrap; background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are in the process of evaluating the effect that the adoption of this standard will have on our financial position and results of operations. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p>
cry Cash Distribution From Escrow
CashDistributionFromEscrow
777000
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
10959000
CY2021Q3 cry Contingent Consideration Current Fair Value
ContingentConsiderationCurrentFairValue
17600000
CY2021Q3 cry Contingent Consideration Noncurrent Fair Value
ContingentConsiderationNoncurrentFairValue
47300000
CY2021Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
64900000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
12439000
CY2020Q4 cry Contingent Consideration Current Fair Value
ContingentConsiderationCurrentFairValue
16430000
CY2020Q4 cry Contingent Consideration Noncurrent Fair Value
ContingentConsiderationNoncurrentFairValue
43500000
CY2020Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
59930000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
409000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
59930000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4970000
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
409000
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
64900000
CY2020Q4 cry Restricted Cash Fair Value Disclosure
RestrictedCashFairValueDisclosure
12030000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2021Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2021Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
34005000
CY2020Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
33625000
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12438000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6318000
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
31876000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
33095000
CY2021Q3 us-gaap Inventory Net
InventoryNet
78319000
CY2020Q4 us-gaap Inventory Net
InventoryNet
73038000
CY2021Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
14700000
CY2020Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
11900000
CY2021Q3 cry Deferred Preservation Costs
DeferredPreservationCosts
42600000
CY2020Q4 cry Deferred Preservation Costs
DeferredPreservationCosts
36500000
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2800000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3500000
CY2021Q3 us-gaap Goodwill
Goodwill
252441000
CY2020Q4 us-gaap Goodwill
Goodwill
260061000
CY2020Q4 us-gaap Goodwill
Goodwill
260061000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-942000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-6678000
CY2021Q3 us-gaap Goodwill
Goodwill
252441000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4203000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3397000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12701000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9430000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4121000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
15944000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
15434000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
15050000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
13002000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
12771000
CY2021Q3 cry Finite Lived Intangible Assets Amortization Expense Estimate
FiniteLivedIntangibleAssetsAmortizationExpenseEstimate
76322000
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.33
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
3.18
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.31
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11600000
CY2021Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
23400000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7200000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
33300000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23300000
CY2021Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0641
CY2021Q3 cry Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
58429000
CY2020Q4 cry Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
28242000
CY2021Q3 cry Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
11516000
CY2020Q4 cry Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
9671000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46913000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5715000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
537000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
614000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4608000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5300000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
190000
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
164000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18571000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3053000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5763000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45765000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14034000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
48818000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
19797000
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
6910000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
7620000
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
2014000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
1905000
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
4896000
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
5145000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
5914000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y4M24D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P9Y9M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.059
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.020
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.020
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
500000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
487000
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
27000
CY2020Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
30000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
85000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
89000
CY2021Q3 cry Finance Lease Cost
FinanceLeaseCost
217000
CY2020Q3 cry Finance Lease Cost
FinanceLeaseCost
194000
cry Finance Lease Cost
FinanceLeaseCost
585000
cry Finance Lease Cost
FinanceLeaseCost
576000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1989000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1806000
us-gaap Operating Lease Cost
OperatingLeaseCost
5566000
us-gaap Operating Lease Cost
OperatingLeaseCost
5324000
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
92000
CY2020Q3 us-gaap Sublease Income
SubleaseIncome
226000
us-gaap Sublease Income
SubleaseIncome
308000
us-gaap Sublease Income
SubleaseIncome
679000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6212000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
612000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5282000
CY2021Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
2963000
us-gaap Operating Lease Payments
OperatingLeasePayments
5438000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
446000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
465000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
82000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
92000
CY2021Q3 us-gaap Lease Cost
LeaseCost
2114000
CY2020Q3 us-gaap Lease Cost
LeaseCost
1774000
us-gaap Lease Cost
LeaseCost
5843000
us-gaap Lease Cost
LeaseCost
5221000
us-gaap Operating Lease Payments
OperatingLeasePayments
4536000
CY2021Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
134000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
680000
CY2021Q3 cry Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear
92000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
642000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6009000
CY2021Q3 cry Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Next Twelve Months
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInNextTwelveMonths
305000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
641000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6601000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
635000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
46618000
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
5627000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
71402000
CY2021Q3 cry Operating Leases Future Minimum Payments Due Sublease Income
OperatingLeasesFutureMinimumPaymentsDueSubleaseIncome
397000
CY2021Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
482000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
22584000
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
5145000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
48818000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
537000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3053000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4608000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45765000
cry Revolving Credit Facility Percentage Repaid For No Covenants
RevolvingCreditFacilityPercentageRepaidForNoCovenants
0.25
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
318363000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
300148000
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
8958000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
8485000
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
309405000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
291663000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1640000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1195000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
307765000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
290468000
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
4100000
us-gaap Interest Expense Debt
InterestExpenseDebt
13000000.0
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
4900000
us-gaap Interest Expense Debt
InterestExpenseDebt
12000000.0
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72207000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65131000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
219442000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
185331000
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
160000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
456000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2990000
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2518000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7895000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7888000
CY2021Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
115000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
424000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
us-gaap Net Income Loss
NetIncomeLoss
5266000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
63000
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-20000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
34000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-93000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10519000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2850000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5232000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13131000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39086000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37912000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38924000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37608000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
us-gaap Net Income Loss
NetIncomeLoss
5266000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
55000
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-20000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
34000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-93000
CY2021Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
919000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
11446000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2850000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5232000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13131000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39086000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37912000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38924000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37608000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
505000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
572000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
4862000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44453000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37912000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39496000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37608000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q3 us-gaap Revenues
Revenues
72207000
CY2020Q3 us-gaap Revenues
Revenues
65131000
us-gaap Revenues
Revenues
219442000
us-gaap Revenues
Revenues
185331000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24418000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21999000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
73302000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62138000
CY2021Q3 us-gaap Gross Profit
GrossProfit
47789000
CY2020Q3 us-gaap Gross Profit
GrossProfit
43132000
us-gaap Gross Profit
GrossProfit
146140000
us-gaap Gross Profit
GrossProfit
123193000
CY2021Q3 us-gaap Revenues
Revenues
72207000
CY2020Q3 us-gaap Revenues
Revenues
65131000
us-gaap Revenues
Revenues
219442000
us-gaap Revenues
Revenues
185331000

Files In Submission

Name View Source Status
0000784199-21-000207-index-headers.html Edgar Link pending
0000784199-21-000207-index.html Edgar Link pending
0000784199-21-000207.txt Edgar Link pending
0000784199-21-000207-xbrl.zip Edgar Link pending
cry-20210930.xsd Edgar Link pending
cry-20210930x10q.htm Edgar Link pending
cry-20210930x10q_htm.xml Edgar Link completed
cry-20210930xex31_1.htm Edgar Link pending
cry-20210930xex31_2.htm Edgar Link pending
cry-20210930xex32.htm Edgar Link pending
cry-20210930_cal.xml Edgar Link unprocessable
cry-20210930_def.xml Edgar Link unprocessable
cry-20210930_lab.xml Edgar Link unprocessable
cry-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending